Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
8 Aug 24
8-K
Kura Oncology Reports Second Quarter 2024
8 Aug 24
S-8
Registration of securities for employees
7 Jun 24
8-K
Departure of Directors or Certain Officers
7 Jun 24
8-K
Other Events
24 May 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
Kura Oncology Reports First Quarter 2024
2 May 24
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
UPLOAD
Letter from SEC
29 Feb 24
S-8
Registration of securities for employees
27 Feb 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
424B3
Prospectus supplement
15 Feb 24
EFFECT
Notice of effectiveness
15 Feb 24
CORRESP
Correspondence with SEC
14 Feb 24
CORRESP
Correspondence with SEC
13 Feb 24
S-3
Shelf registration
9 Feb 24
D
Exempt offering of security
5 Feb 24
8-K
Results of Operations and Financial Condition
30 Jan 24
8-K
Kura Oncology Announces Oversubscribed
26 Jan 24
8-K
Other Events
22 Dec 23
S-3ASR
Automatic shelf registration
2 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Kura Oncology Reports Third Quarter 2023
2 Nov 23
8-K
Entry into a Material Definitive Agreement
1 Sep 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Kura Oncology Reports Second Quarter 2023
3 Aug 23
8-K
Kura Oncology Announces Commencement of Public Offering of Common Stock and Pre-Funded Warrants
14 Jun 23
424B5
Prospectus supplement for primary offering
14 Jun 23
424B5
Prospectus supplement for primary offering
13 Jun 23
8-K
Other Events
12 Jun 23
S-8
Registration of securities for employees
2 Jun 23
8-K
Departure of Directors or Certain Officers
2 Jun 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Kura Oncology Reports First Quarter 2023
10 May 23
DEFA14A
Additional proxy soliciting materials
4 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
8-K
Other Events
19 Apr 23
Latest ownership filings
4
Mary T Szela
7 Jun 24
4
Diane L. Parks
7 Jun 24
4
CAROL SCHAFER
7 Jun 24
4
Thomas Malley
7 Jun 24
4
Faheem Hasnain
7 Jun 24
4
Helen Louise Collins
7 Jun 24
4
Teresa Brophy Bair
20 May 24
144
Notice of proposed sale of securities
20 May 24
SC 13G
Paradigm Biocapital Advisors LP
2 May 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Flynn James E
12 Feb 24
4
THOMAS JAMES DOYLE
31 Jan 24
4
KATHLEEN FORD
31 Jan 24
4
Teresa Brophy Bair
31 Jan 24
4
STEPHEN DALE
31 Jan 24
144
Notice of proposed sale of securities
30 Jan 24
4
TROY EDWARD WILSON
26 Jan 24
144
Notice of proposed sale of securities
24 Jan 24
SC 13G/A
BlackRock Inc.
24 Jan 24
SC 13G/A
STATE STREET CORP
23 Jan 24
4
THOMAS JAMES DOYLE
4 Jan 24
4
Brian T. Powl
4 Jan 24
4
KATHLEEN FORD
4 Jan 24
4
Teresa Brophy Bair
4 Jan 24
4
STEPHEN DALE
4 Jan 24
4
TROY EDWARD WILSON
4 Jan 24
4
TROY EDWARD WILSON
11 Dec 23
SC 13G
Flynn James E
21 Sep 23
4
Brian T. Powl
16 Aug 23
3
Brian T. Powl
16 Aug 23
4
Thomas Malley
21 Jun 23
4
TROY EDWARD WILSON
2 Jun 23
4
Mary T Szela
2 Jun 23
4
CAROL SCHAFER
2 Jun 23
4
Diane L. Parks
2 Jun 23
4
Thomas Malley
2 Jun 23
4
Faheem Hasnain
2 Jun 23